Human growth hormone plays a vital role in health and well-being, particularly as its levels decrease with age, leading to common age-related issues
Its Novo Nordisk relationship has been publicly announced, its pharmacy relationships are disclosed more clearly, and the business files quarterly SEC reports that investors and patients can review
Supporters argued that the peptide has been used in practice for years and warrants broader access and additional study
Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling
It presents a key barrier to equitable access to this great innovation. In pursuit of more equitable and cost-effective approaches to leveraging GLP-1RAs, Kim and a group of other researchers analyzed the potential impact of alternative weight loss programs
A Certificate of Analysis (CoA) is available upon request
